Residency · Residency · Internal Medicine

Status Epilepticus: Emergency Management

Start here

Alright, it’s 3 AM, and the charge nurse just called. Mr. Henderson, down in room 3, is seizing. You walk in to find him thrashing, eyes rolled back, foam at his mouth. This isn't just a seizure; this is Status Epilepticus (SE), and every second counts. Your brain is probably a little foggy right now, but remember this: the longer he seizes, the higher the risk of permanent brain damage and even death. Think of it like a fire—the faster you put it out, the less destruction.

Your first move is always to stabilize. Get him on his side, protect his airway, slap an oxygen mask on him. While your excellent nurse is doing that, you’re barking orders for two large-bore IVs. Don’t forget that fingerstick glucose; if he's hypoglycemic, a quick push of D50 could be the only thing he needs. If you suspect alcoholism or malnutrition, preemptively give thiamine before the D50. Labs are important, but not at the expense of stopping the seizure. Get the basic metabolic panel (BMP), complete blood count (CBC), calcium, magnesium, and maybe an antiepileptic drug (ASM) level if he’s on one. But critically, don't let those labs delay the next step.

Now, the main event: benzodiazepines. This is your first line of defense. Think of them as your immediate fire extinguisher. You'll want to give lorazepam 4mg IV. If you can't get an IV in right away, don't waste precious minutes; just give midazolam 10mg IM. The RAMPART trial showed that IM midazolam is just as effective as IV lorazepam and often gets into the patient faster in an emergency. If that first dose doesn't stop it in five minutes, hit him with another one. If after two doses he’s still seizing, you need a different fire truck. Call me, and let’s talk about a second-line agent like levetiracetam. Remember, the goal is to stop the seizure, and stop it fast.

Introduction

Status epilepticus (SE) is a neurologic emergency defined as continuous seizure activity lasting 5 minutes or longer, or two or more seizures without return to baseline between episodes. Convulsive SE carries a mortality rate of 10-30% and the risk of permanent neurologic injury increases with each minute of ongoing seizure activity. A structured, time-based protocol with immediate benzodiazepine administration is critical to improving outcomes.

Definitions and Classification

• Convulsive status epilepticus (CSE): continuous generalized tonic-clonic seizure activity >= 5 minutes
• Non-convulsive status epilepticus (NCSE): electrographic seizure activity without prominent motor manifestations; often presents as altered mental status, confusion, or subtle eye movements
• Refractory SE (RSE): seizures persisting despite adequate first-line (benzodiazepine) and second-line antiseizure medication
• Super-refractory SE (SRSE): seizures continuing >= 24 hours after initiation of anesthetic agents, or recurring upon anesthetic withdrawal
• Established SE: seizures lasting >= 30 minutes without treatment; associated with excitotoxic neuronal injury, receptor trafficking (GABA receptor internalization, NMDA receptor externalization), and progressive pharmacoresistance

Etiology

Common Causes in Adults

• Antiseizure medication (ASM) non-adherence or withdrawal: most common cause in known epilepsy patients
• Acute structural lesion: stroke, hemorrhage, traumatic brain injury, brain tumor
• CNS infection: meningitis, encephalitis (HSV), brain abscess
• Metabolic derangements: hypoglycemia, hyponatremia, hypocalcemia, uremia, hepatic encephalopathy
• Toxic exposures: alcohol withdrawal, benzodiazepine withdrawal, drug overdose (sympathomimetics, isoniazid)
• Autoimmune encephalitis: anti-NMDA receptor encephalitis, LGI1 antibody encephalitis
• Anoxic brain injury: post-cardiac arrest

Time-Based Treatment Protocol

Phase 1: Stabilization (0-5 Minutes)

• ABCs: secure airway, suction secretions, position in lateral decubitus, supplemental oxygen
• IV access: obtain two large-bore IVs
• Fingerstick glucose: administer dextrose 50% (25-50 mL IV) if hypoglycemic
• Thiamine 100 mg IV before or with dextrose (if alcoholism or malnutrition suspected)
• Labs: BMP, CBC, calcium, magnesium, ASM levels, toxicology screen, ABG
• Do NOT: place objects in the mouth, restrain the patient forcefully

Phase 2: First-Line Therapy -- Benzodiazepines (5-20 Minutes)

• IV lorazepam: 0.1 mg/kg (max 4 mg), repeat once in 5 minutes if seizures continue
• IM midazolam: 10 mg IM (> 40 kg) if no IV access; RAMPART trial demonstrated IM midazolam non-inferior to IV lorazepam with faster time-to-treatment in the prehospital setting
• IV diazepam: 0.15 mg/kg (max 10 mg) if lorazepam unavailable
• Rectal diazepam or intranasal midazolam: alternatives when IV/IM access is not available
• Benzodiazepines terminate seizures in approximately 65% of cases when given promptly

Phase 3: Second-Line Therapy -- Urgent Control (20-40 Minutes)

If seizures persist after adequate benzodiazepine doses:

• IV levetiracetam: 60 mg/kg (max 4500 mg) infused over 10 minutes; fewest drug interactions, no hemodynamic effects
• IV fosphenytoin: 20 mg PE/kg at 150 mg PE/min; monitor for hypotension and arrhythmia; avoid in known cardiac conduction disease
• IV valproate: 40 mg/kg (max 3000 mg) infused over 10 minutes; avoid in pregnancy, hepatic failure, mitochondrial disease, pancreatitis
• ESETT trial: levetiracetam, fosphenytoin, and valproate are equally effective as second-line agents (seizure cessation in approximately 45% each); choice should be based on patient-specific factors

Phase 4: Refractory SE -- Third-Line Therapy (> 40 Minutes)

• Intubation and continuous IV anesthetic infusion:
• Midazolam: 0.2 mg/kg bolus, then 0.1-2 mg/kg/hour infusion
• Propofol: 2 mg/kg bolus, then 30-200 mcg/kg/min; monitor for propofol infusion syndrome (metabolic acidosis, rhabdomyolysis, cardiac failure) if > 48 hours or > 5 mg/kg/hour
• Pentobarbital: 5 mg/kg bolus, then 1-5 mg/kg/hour; most potent but greatest hemodynamic compromise
• Continuous EEG (cEEG) monitoring: mandatory to guide anesthetic titration; target burst suppression or seizure suppression
• Maintain anesthetic infusion for 24-48 hours, then slowly wean while monitoring for seizure recurrence

Non-Convulsive Status Epilepticus

• Suspect in any patient with unexplained altered mental status, particularly after convulsive seizures
• Diagnosis requires continuous EEG monitoring
• Common in the ICU: up to 20% of comatose ICU patients have NCSE
• Treat with the same stepwise protocol, though urgency may be slightly less than in convulsive SE
• Post-cardiac arrest: electrographic seizures common but treatment decisions are complex; avoid aggressive anesthetic therapy if prognosis is poor

Special Considerations

• Isoniazid toxicity: treat with pyridoxine (vitamin B6) gram-for-gram replacement (5 g IV if dose unknown)
• Eclampsia: magnesium sulfate is the agent of choice (not benzodiazepines)
• Alcohol withdrawal seizures: typically self-limited; benzodiazepines are first-line; phenobarbital is an effective alternative
• Anti-NMDA receptor encephalitis: immunotherapy (steroids, IVIG, plasmapheresis) alongside ASMs

Key Clinical Pearls

• Give benzodiazepines IMMEDIATELY; every minute of delay reduces the probability of seizure termination
• IM midazolam is as effective as IV lorazepam and can be administered faster when IV access is not established (RAMPART trial)
• Levetiracetam, fosphenytoin, and valproate are equally effective second-line agents (ESETT trial); choose based on comorbidities and drug interactions
• Always obtain continuous EEG monitoring in refractory SE and in any patient who does not return to baseline mental status after seizure cessation

References

1. Glauser T, Shinnar S, Gloss D, et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults (AAN/AES). Epilepsy Curr. 2016;16(1):48-61.
2. Kapur J, Elm J, Chamberlain JM, et al. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus (ESETT). N Engl J Med. 2019;381(22):2103-2113.
3. Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus Intravenous Therapy for Prehospital Status Epilepticus (RAMPART). N Engl J Med. 2012;366(7):591-600.
4. Brophy GM, Bell R, Claassen J, et al. Guidelines for the Evaluation and Management of Status Epilepticus. Neurocrit Care. 2012;17(1):3-23.

For the intern

At 3am, status epilepticus (SE) is an emergency requiring immediate action. Give benzodiazepines NOW—lorazepam 4 mg IV or midazolam 10 mg intramuscular (IM) if no intravenous (IV) access. Check fingerstick glucose and give dextrose 50% if low. Secure airway, position lateral, obtain IV access, and send labs. If seizures continue after 10 minutes, load a second-line agent: levetiracetam 60 mg/kg IV is safest at night. Call neurology early but do NOT wait for them to start treatment. If seizures persist beyond 40 minutes, prepare for intubation and anesthetic infusion—you'll need intensive care unit (ICU) transfer and continuous electroencephalography (EEG). What can wait: detailed workup for etiology (magnetic resonance imaging, lumbar puncture unless meningitis suspected) and fine-tuning maintenance antiseizure medication can happen in daylight. Never delay benzodiazepines—pharmacoresistance increases with each passing minute.

Common pitfalls

• Waiting for IV access to treat: IM midazolam works as well as IV lorazepam and is faster when veins are difficult. Don't hesitate to use the IM route.
• Underdosing benzodiazepines: Give full weight-based doses (lorazepam 0.1 mg/kg, up to 4 mg). Repeating inadequate doses wastes time.
• Delaying second-line therapy: If seizures continue 5 minutes after the second benzodiazepine dose, immediately load levetiracetam, fosphenytoin, or valproate—don't wait and watch.
• Missing non-convulsive SE: Any patient with persistent altered mental status after apparent seizure cessation needs continuous EEG monitoring to rule out ongoing electrographic seizures.

Make it stick

Imagine you're the admitting intern, 3 AM, and the Emergency Department (ED) calls: "We have a 72-year-old in continuous generalized convulsive status epilepticus, actively seizing. We can't get IV access." Your heart rate spikes. Your role is critical. You advise the ED to give intramuscular (IM) midazolam immediately, as that's faster than waiting for IV access, per the RAMPART trial. You order labs, prepare for IV lorazepam for when they get access, and arrange for a rapid response. You know every minute counts. Your quick, decisive action here can prevent permanent brain damage and even save a life.

If you remember one thing

Administer benzodiazepines immediately (IM midazolam if no IV access, otherwise IV lorazepam) as the first and most critical step in status epilepticus management; every minute of delay increases the risk of pharmacoresistance and worse patient outcomes. Second-line agents (levetiracetam, fosphenytoin, valproate) should be initiated promptly if seizures persist after adequate benzodiazepine dosing.

Read this lecture as Markdown